Ramopharmin

Ramopharmin is a well-established Iranian pharmaceutical company headquartered in Tehran, specializing in the development and large-scale manufacturing of generic medicinal products. Founded in 1962, the company has grown into a key player in the regional healthcare sector, producing a diverse portfolio that includes analgesics, cardiovascular drugs, antibiotics, and gastrointestinal treatments. The firm operates modern manufacturing facilities that comply with international Good Manufacturing Practice (GMP) standards, enabling the production of various dosage forms such as tablets, capsules, syrups, and oral drops. As a subsidiary of the Tamin Pharmaceutical Investment Company (TPICO), Ramopharmin plays a vital role in ensuring the domestic supply of essential and affordable medicines within Iran. The company focuses on maintaining high quality control standards while expanding its reach into neighboring export markets. Its long-standing history and integrated production capabilities make it a cornerstone of the Iranian pharmaceutical industry.